Genes
Oligo Pools
NGS
Variant Libraries
Antibodies
IVDR Solutions
Technical Note
Protocol
Product Sheet
Twist Bioscience HQ
681 Gateway Blvd
South San Francisco, CA 94080
UltraSensitive Residual Leukemia Detection with Patient-Specific Duplex Sequencing
Dr. Jesse Salk reviews using Duplex Sequencing to measure ultra-rare mutations from carcinogens, aging, and the earliest stages of cancer.
Covered in this Webinar
Goals of TwinStrand Biosciences
Duplex Sequencing technology versus standard sequencing
Capturing ultra-rare mutations from sequencing data
Jesse Salk, MD, PhD, is the CEO and CSO of TwinStrand Biosciences. He explains the challenges of finding a genetic needle in a haystack and shares how Twist's technology and target enrichment solutions help him achieve the otherwise "crazy" results he's seeking from patient samples using duplex sequencing.
Share your details to Watch the Webinar
